Accessibility Tools

Shared Care Guidelines


Alemtuzumab for Treating Multiple sclerosis shared care Guideline – Updated


The updated SCG was ratified for local use for patients under the care of Addenbrooke’s Hospital only.

The alemtuzumab shared care guideline has been updated by Cambridge & Peterborough ICS and has been ratified by the Bedfordshire, Luton and Milton Keynes Area Prescribing Committee (APC) , May 2023

View Document

Guideline Categories: Neurology

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: alemtuzumab, mhra, ms, multiple, multiple sclerosis, sclerosis

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net